Abstract
Study summary
This preprint integrates genomics, transcriptomics, methylation, spatial profiling, morphology, and clinical data to refine the classification of lung neuroendocrine tumours. The proposed morpho-molecular groups expose clinically relevant tumour states and potential therapeutic opportunities, including markers connected to prognosis and treatment selection.